Discontinuation report INTRON A
Report ID | 33898 |
Drug Identification Number | 02240693 |
Brand name | INTRON A |
Common or Proper name | interferon alfa-2b solution for injection (multi-dose pen) |
Company Name | MERCK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | INTERFERON ALFA-2B |
Strength(s) | 15000000UNIT |
Dosage form(s) | LIQUID |
Route of administration | SUBCUTANEOUS |
Packaging size | 18MIU PEN |
ATC code | L03AB |
ATC description | IMMUNOSTIMULANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2019-01-07 |
Remaining supply date | 2019-01-07 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Decision to discontinue is business-related only. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-12-20 | English | Compare |
v2 | 2017-12-20 | French | Compare |
v3 | 2018-02-25 | English | Compare |
v4 | 2018-12-21 | English | Compare |
v5 | 2019-01-07 | English | Compare |
Showing 1 to 5 of 5